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ABSTRACT
Telomere-specific repeat sequences are essential for
chromosome end stability. Telomerase maintains
telomere length by adding sequences de novo onto
chromosome ends. The template domain of the
telomerase RNA component dictates synthesis of
species-specific telomeric repeats and other regions
of the RNA have been suggested to be important for
enzyme structure and/or catalysis. Using enzyme
reconstituted in vitro with RNAs containing deletions or
substitutions we identified nucleotides in the RNA
component that are important for telomerase activity.
Although many changes to conserved features in the
RNA secondary structure did not abolish enzyme
activity, levels of activity were often greatly reduced,
suggesting that regions other than the template play a
role in telomerase function. The template boundary was
only altered by changes in stem II that affected the
conserved region upstream of the template, not by
changes in other regions, such as stems I, III and IV,
consistent with a role of the conserved region in defining
the 5′ boundary of the template. Surprisingly, telomerase
RNAs with substitutions or deletion of residues
potentially abolishing the conserved pseudoknot
structure had wild-type levels of telomerase activity. This
suggests that this base pairing interaction may not be
required for telomerase activity per se but may be
conserved as a regulatory site for the enzyme in vivo.
INTRODUCTION
In Tetrahymena and yeast altering telomere sequences by
expression of a mutated telomerase RNA template results in
deregulation of telomere length and eventual cell death. Deletion
of TLC1, the gene encoding the Saccharomyces cerevisiae
telomerase RNA, results in telomere shortening and cell death.
Thus telomerase is critical for telomere length maintenance
(1–3). The RNA component of telomerase is best characterized
in ciliates, where it has been cloned from 24 species (4; reviewed
in 5). The telomerase RNAs of different ciliate species range from
148 to 209 nt in length and contain short sequences of 9–15 nt that
are complementary to the species-specific telomeric repeats. For
example, Tetrahymena telomeres consist of TTGGGG repeats and
the telomerase RNA contains the sequence 5′-CAACCCCAA-3′.
With the exception of the template region and a conserved sequence
adjacent to the template, the ciliate telomerase RNAs share little
primary sequence identity (4,6,7).
To identify potential functional domains in the Tetrahymena
telomerase RNA, a secondary structure model was derived from
phylogenetic sequence comparison of telomerase RNAs from
different tetrahymenine ciliates (8,9). A secondary structure for
the Tetrahymena telomerase RNA was proposed that includes
four conserved helices, numbered 5′→3′ as helices I–IV (Fig. 1).
In the proposed structure helix I involves long range base pairing,
establishing the superstructure of the RNA, and is the most
conserved of the helices. Helices II, III and IV are stem–loop
structures. Conservation of stem–loop structures is often
indicative of protein binding domains (10,11). Helix II is not
conserved in all ciliates, however, upstream of the template there
is a conserved sequence, 5′-(CU)GUCA-3′, which plays a role in
defining the 5′ boundary of the template domain (7,9,12). An
unstructured region is predicted between helices II and III and
includes the template sequence. Nucleotides in the loop of helix
III can base pair with a single-stranded region just upstream of the
helix III stem, to form a pseudoknot (13). Pseudoknot structures are
also often involved in the recognition and binding of proteins
(14,15). Helix IV has the highest primary sequence conservation of
the stem–loops. It was proposed that the conserved nucleotides of
helix IV could be involved in alternative base pairing that might help
mediate a conformational change during the translocation step of
telomerase substrate elongation (8).
Chemical modification studies of the Tetrahymena thermophila
and Glaucoma chattoni telomerase RNAs in vivo and in vitro
support the phylogenetically derived secondary structure model,
although some differences are seen between naked RNA and the
RNP complex (16,17). Structural probing of the naked RNA of
helix III suggests that this region is in an equilibrium favoring one
of two helical structures. Conformational change between
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Figure 1. Diagram of the secondary structure of the Tetrahymena telomerase
RNA, including the pseudoknot structure (brackets) (8,13). The telomerase
RNA sequence is shown with functional domains, including the template and
alignment regions 5′-CAACCCCAA-3′ (residues 43–51, white box) and the
upstream conserved region 5′-(CU)GUCA-3′ (residues 35–40, shaded box),
which regulates the 5′ boundary of the template (7,12,20). The 159 nt
Tetrahymena telomerase RNA is marked 5′→3′ every 10 residues.
pseudoknot and hairpin states might be relevant to the enzymatic
action of telomerase (7). A structurally conserved kink at the GA
bulge in helix IV has been proposed to serve as a recognition
motif for protein binding (16). Comparison of methylation
patterns of protein-free telomerase RNA to that of RNA
complexed with protein implicated protein binding for the hairpin
loop of stem III adjacent to the pseudoknot, the GA bulge in stem
IV and three sites around residues 15 and 16, 39 and 62 (17).
Telomerase RNAs from hypotrichous ciliates and Paramecium
species can be folded into a conserved secondary structure similar
to the derived Tetrahymena structure (4,6,7). Telomerase RNAs
from human, mouse and the yeasts Saccharomyces cerevisiae and
Kluyveromyces lactis are longer and secondary structure predictions
await phylogenetic comparisons and structural probing of the
mammalian and yeast telomerase RNAs (2,3,18,19).
In Tetrahymena and human, in vitro reconstitution of telomer-
ase activity from isolated protein and mutated RNA components
has been instrumental in identification of functional domains of
the telomerase RNA (12,20,21). To address the function of the
conserved secondary structures of the telomerase RNA we
analyzed the activity of Tetrahymena telomerase reconstituted in
vitro with telomerase RNAs containing deletions or substitutions
in specific secondary structures.
MATERIALS AND METHODS
Purification of oligonucleotides
Oligonucleotides were synthesized by Operon Technologies
(Alameda, CA) or by the oligonucleotide facility at Cold Spring
Harbor Laboratory. Oligonucleotides were purified as previously
described (20) and concentrations were determined spectro-
photometrically assuming 1 OD260 unit equals 20 µg/ml.
Preparation of Tetrahymena telomerase
Tetrahymena telomerase was purified using a protocol modified
from Collins et al. (21). Tetrahymena strains CU428 (kindly
provided by Martin Gorovsky) were grown with shaking at 30C
to a density of 4.0 × 105 cells/ml in 2 × 36 l medium (2% proteose
peptone, 0.2% yeast extract, 10 µM FeCl3) supplemented with
250 µg/l both ampicillin and streptomycin. After harvesting the
cells were resuspended in Dryls starvation medium (1.7 mM
sodium citrate, 2.4 mM sodium phosphate, 2 mM CaCl2) and
incubated at 30C for 18 h. Cells were harvested and resuspended
in 2× the volume of the cell pellet of T2MG (20 mM Tris–HCl,
pH 8.0, 1 mM MgCl2, 10% glycerol) with 5 mM β-mercaptoethanol
(β-me), 0.1 mM PMSF and protease inhibitors (0.25 µg/ml each
leupeptin and pepstatin; Sigma). Lysis was enhanced by stirring
the cells in this buffer at 4C for 20 min in the presence of 0.2%
NP-40 (Sigma). The lysed cells were centrifuged at 40 000 r.p.m.
for 1 h in a Ti45 rotor (Beckman) at 4C and the supernatant
(S130 extract) collected and stored at –70C after quick freezing
in liquid nitrogen.
DEAE-purified telomerase was prepared as follows. S130
extract (255 ml, 1900 mg protein) was loaded onto a 150 ml
ceramic hydroxyapatite (AIC) column equilibrated in T2MG
with β-me and protease inhibitors as described above. Proteins
were eluted with a 380 ml gradient to 0.2 M K2HPO4 in T2MG.
The ceramic hydroxyapatite column was regenerated and
equilibrated in T2MG and the second S130 fraction (225 ml,
2700 mg protein) loaded onto the column. Similarly, proteins
were eluted with a 380 ml gradient to 0.2 M K2HPO4 in T2MG.
Fractions containing maximal telomerase activity from the first
ceramic hydroxyapatite column (580 mg) were loaded, after
diluting 3-fold with T2MG, onto an 18 ml spermine–agarose
(Sigma) column equilibrated in T2MG with 0.15 M potassium
glutamate (Kglu). Proteins were eluted in T2MG with 0.65 M
Kglu. Fractions containing maximal telomerase activity from the
second ceramic hydroxyapatite column (95 mg) were loaded,
after diluting 3-fold with T2MG, on a 3 ml spermine–agarose
column as before. Proteins were eluted in T2MG with 0.65 M
Kglu. Fractions with maximal telomerase activity from both
spermine–agarose columns were pooled (60 ml, 48 mg) and
loaded onto a 6 ml phenyl-Sepharose (Pharmacia) column
equilibrated in T2MG with 0.6 M Kglu. Proteins were eluted in
T2MG without salt and in T2MG with 1% Triton X-100.
Fractions containing maximal telomerase activity in the no salt
elution (45 ml, 6 mg) were loaded, after adjusting to no salt, onto
a 2 ml DEAE–agarose (BioRad) column equilibrated in T2MG.
Protein was eluted in T2MG with 0.4 M Kglu. The peak of
telomerase was in fraction 3 (2 ml, 4 mg). For the experiments in this
study fraction 4 was used (2 ml, 2.2 mg). DEAE-purified telomerase
(1.1 mg protein/ml extract) was diluted 5-fold with T2MG before
use in reconstitution reactions. The extract preparations remained
active in elongation assays and in reconstitution assays for at least
24 months when stored at –70C. Protein concentrations were
determined by a Bradford assay with BioRad dye reagent.
Telomerase elongation activity assay
Telomerase assays were done as previously described (23). Briefly,
20 µl extract were added to 20 µl 2× reaction mix. The final
concentrations of the components in the assay were 1× telomerase
buffer (50 mM Tris–HCl, pH 8.5, 1 mM spermidine, 5 mM β-me
and 50 mM KOAc), 800 nM primer oligonucleotide (0.2 µg),
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100 µM dTTP and 0.3125 µM [α-32P]dGTP (1 µl 800 Ci/mmol;
NEN). In assays with telomerase reconstituted with certain
mutated RNAs, reaction mixes contained 100 µM both dTTP and
dATP. In reactions with dideoxynucleotides ddTTP (100 µM)
replaced dTTP. Reaction times were 1 h at 30C. Reactions were
stopped by adding 100 µl 21 mM EDTA, 10 mM Tris–HCl, pH
7.5, and 1.5 µg/ml DNase-free RNase (Boehringer Mannheim).
After phenol extraction 60 µl 2.5 M NH4OAc, 100 µg/ml
Escherichia coli tRNA (Sigma) and ethanol were added to the
reactions and precipitated overnight at –20C. Products were
centrifuged, pellets dried and resuspended in formamide containing
xylene cyanol. Samples were boiled, cooled on ice and loaded onto
8% polyacrylamide–7 M urea gels and electrophoresed at 1500 V
for 2 h using 0.6× TBE buffer. Gels were dried, exposed to Fuji
PhosphorImager screens for 16–24 h and then exposed to film
(XAR5) for 10 days, unless otherwise indicated in the figures.
Products were quantified by comparing the signal intensity for the
first repeat in each lane using a BAS2000 PhosphorImager. The
signal intensity in the no RNA lane was subtracted as background.
Micrococcal nuclease treatment and reconstitution assay
conditions
DEAE-purified Tetrahymena telomerase extract was incubated with
0.1 U/µl extract micrococcal nuclease (MNase; Pharmacia) and
1 mM CaCl2 for 10 min at 30C. The MNase was inactivated by
adding 2.5 mM EGTA. MNase was prepared as previously
described (20). Under standard reconstitution conditions MNase-
treated telomerase extract (∼0.2 mg/ml protein) containing no
detectable telomerase activity was incubated with 5 mM EDTA and
200 ng in vitro transcribed telomerase RNA per 20 µl extract.
Incubation was for 5 min at 37C. One microliter of 200 mM MgCl2
was added prior to assaying for elongation activity.
Site-directed mutagenesis
Using a methodology similar to that previously described (20) or
using site-directed mutagenesis by overlap extension (24)
plasmids containing mutated versions of the Tetrahymena
telomerase RNA gene were constructed. Oligonucleotides with
sequences corresponding to mutations at the desired positions in
the RNA gene were synthesized and used in PCR, with pT7159
digested with EcoRI and HindIII as template (20) or pCG1
digested with HindIII as template (25).
For mutations at the 5′-end of the RNA, ∆5′8, the oligonucleotide
at the 3′-end was 3′T7PCR and the template used was pT7159. The
sequence of the 3′T7PCR oligonucleotide was 5′-CAGT-
GAATTCGAGCTCGGTACCCGGGG-3′, which includes an
EcoRI restriction site. For mutations at the 5′-end of the RNA,
including ∆5′11, ∆5′15, ∆5′19, ∆5′2525, ∆5′36, sub4–8 and
sub15–16, the oligonucleotide at the 3′-end was CG1BamHI and
the template used was pCG1. The sequence of CG1BamHI was
5′-CCCCGGATCCAAAAAAAATAAGACATCCATTG-3′,
which includes a BamHI restriction site. The sequences of the
mutation-specific oligonucleotides were 5′-AGGGGTCTAGA-
TAATACGACTCACTATAGGGTTAATTCATTC-3′ (d58),
5′-GGGGTCTAGATAATACGACTCACTATAGGGATTCATT-
CAGATCTGTAATAG-3′ (d511), 5′-GGGGTCTAGATAATAC-
GACTCACTATAGGGATTCAGATCTGTAATAGAACT-3′
(d515), 5′-GGGGTCTAGATAATACGACTCACTATAGGGA-
GATCTGTAATAGAACTGTC-3′ (d519), 5′-GGGGTCTAGA-
TAATACGACTCACTATAGGGGTAATAGAACTGTCATTC-
AA-3′ (d525), 5′-GGGGTCTAGATAATACGACTCACTATA-
GGGGTCATTCAACCCCAAAAATC-3′ (d536), 5′-GGGGTC-
TAGATAATACGACTCACTATAGGGATAAAACATTAATTCA-
TTCAGATCTGT-3′, (S1AAACA), 5′-GGGTCTAGATAATACG-
ACTCACTATAGGGATACCCGCTTAATTGTTTCAGA-3′
(1516GT) and include a XbaI restriction site.
For mutations at the 3′-end of the RNA, including t146, t138, t111
and t75, the 5′ oligonucleotide used was 5′T7 and the template used
was either pT7159 (t146) or pCG1 (t138, t111 and t75). The
sequence of 5′T7 was 5′-GGGGTCTAGATAATACGACTCAC-
TATAGGGATACCCGCTTAATTCATTCA-3′ and includes a XbaI
restriction site. The sequences of the mutation-specific oligonucleo-
tides were 5′-CCCCGAATTCCATTGATAAATAGTGTA-3′
(d313), 5′-CCCCGGATCCAATAGTGTATCAAATGTCGA-3′
(d321), 5′-CCCCGGATCCTTGTCCCGCATTACCACTTA-3′
(d348) and 5′-CCCCGGATCCGAAGGTTATATCAGCAC-
TAG-3′ (d384) and include an EcoRI restriction site (d313) or a
BamHI restriction site (d321, d348 and d384). PCR amplification
was performed in a 100 µl volume in the presence of 1 µM each
primer and 1 ng template DNA. Five units of Taq polymerase
(Perkin-Elmer Cetus) were used in 1× PCR buffer (50 mM KCl,
10 mM Tris–HCl, pH 8.3, 1.5 mM MgCl2) and 250 µM dNTPs.
Reactions were cycled 30 times for 1 min at 94C, 1 min at 46C
and 1 min at 72C.
The PCR-amplified DNAs were cleaved with either XbaI and
EcoRI and cloned into pT7159 cleaved with the same enzymes or
XbaI and BamHI and cloned into pUC119 cleaved with the same
enzymes, using conventional cloning techniques (26). The
resulting clones (listed below) contained the mutated versions of
the telomerase RNA gene downstream of the T7 promoter, as
confirmed by sequencing both strands of the inserted DNA by the
dideoxy-mediated chain termination method as per the
manufacturer’s instructions (US Biochemical).
For the mutated genes constructed by overlap extension two
fragments per mutated gene were initially generated using similar
PCR conditions as described above. For all PCR reactions, except
those noted below, the template used was pCG1 digested with
HindIII. The equivalent of 0.1 µl (∼10 ng PCR product) of the two
100 µl PCR reactions were then combined, in a second PCR,
using the outermost 5′ and 3′ oligonucleotides used in the first two
PCR reactions (generally 5′T7 and CG1BamHI, except where
noted below) to construct the desired mutated gene. The
PCR-amplified DNAs were cleaved with XbaI and BamHI and
cloned into pUC119 cleaved with the same enzymes. The
resulting clones were sequenced as described above.
For the mutation ∆20–36, primers 5′T7 and d2036b were used
with pT7159 digested with XbaI and BamHI as template. Primers
d2036c and CG1BamHI were used to generate the second
fragment. For sub26–29 the template used was pT7159 digested
with HindIII and EcoRI. The primers used in the first step were
5′T7159XbaI and 26CATTb and 26CATTc and CG1BamHI. In
the second step primers 5′T7159XbaI and CG1BamHI were used.
For ∆37–40 in the first step PCR primers 5′T7 and d3740b were
used to generate one fragment and primers d3740c and
CG1BamHI were used to generate the second fragment. For sub
69–72 the oligonucleotides used were 5′T7 and 69TTGGb and
69TTGGc and CG1BamHI. For ∆76–99 primers 5′T7 and
d7699b were used to generate one fragment and d7699c and
CG1BamHI were used to generate the second fragment. For
sub84–87 primers 5′T7 and S38487b were used for one fragment
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and S38487c and CG1BamHI for the other. For sub89–90, primers
5′T7 and 89TTb and 89TTc and CG1BamHI were used. For the
mutation ∆103–107, in the first step PCR, primers 5′T7 and
d103107b were used for one fragment and primers d103107c and
CG1BamHI were used for the other fragment. For sub121–122
primers 5′T7 and 121CTb were used as well as 121CTc and
CG1BamHI. For sub133–136 the template used was pT7159
digested with HindIII and EcoRI. The primers were 5′T7159XbaI
and 133TGATb and 133TGATc and 3′T7PCR. In the second step
5′T7159XbaI and 3′T7PCR were used. The sequences of the
primers were 5′-GTTGAATGACGAATGAATTAAGCGGGT-
AT-3′ (d2036b), 5′-TAATTCATTCGTCATTCAACCCCAAA-
AATC-3′ (d2036c), 5′-GACAGTTCTAAATGAGATCTGA-
AT-3′ (26CATTb), 5′-ATTCAGATCTCATTTAGAACTGTC-3′
(26CATTc), 5′-TGGGGTTGAAAGTTCTATTACAGATCTG-
AA-3′ (d3740b), 5′-TAATAGAACTTTCAACCCCAAAAAT-
CTAGT-3′ (d3740c), 5′-AATTGGTGAACCAAATATCAGC-
AC-3′ (69TTGGb), 5′-GTGCTGATATTTGGTTCACCAATT-3′
(69TTGGc), 5′-GTCCCGCATTGAAGGTTATATCAGCAC-
TAG-3′ (d7699b), 5′-TATAACCTTCAATGCGGGACAAAAG-
ACTAT-3′ (d7699c), 5′-CCACTTATTTGTTGGTAATTGGT-
GA-3′ (S38487b), 5′-TCACCAATTACCAACAAATAAGTGG-3′
(S38487c), 5′-TTACCACTTATAAGAACCTAATT-3′ (89TTb),
5′-AATTAGGTTCTTATAAGTGGTAA-3′ (89TTc), 5′-AGTCT-
TTTGTATTACCACTTATTTGAACCT-3′ (d103107b), 5′-AAGT-
GGTAATACAAAAGACTATCGACATTT-3′ (d103107c), 5′-TG-
TATCAAATGAGGATAGTCTTT-3′ (121CTb), 5′-AAAGAC-
TATCCTCATTTGATACA-3′ (121CTc), 5′-CCATTGATAAAAT-
CAGTATCAAATG-3′ (133TGATb), 5′-CATTTGATACTGATTT-
TATC-AATGG-3′ (133TGATc), 5′-GGGGTCTAGATAATACG-
AC-3′ (5′T7159XbaI).
Preparation of RNAs
RNAs used in reconstitution assays were in vitro transcribed with T7
RNA polymerase (Stratagene) using pT7159 and p5′8 digested with
FokI, pt111 and pt138 digested with BamHI, pt146 digested with
EcoRI, p4–8AAACA, p∆5′11, p∆5′15, p15–16GT, p∆5′19,
p∆20–36, p∆5′25, p26–29CATT, p∆5′36, p∆36–40, p69–72TTGG,
pt75, p∆76–99, p84–87CCAA, p89–90TT, p∆103–107,
p121–122CT and p133–136TGAT digested with XbaI and BamHI
as templates. p38–40AGT was prepared as previously described
(12). Standard in vitro transcription reaction conditions
recommended by the T7 RNA polymerase manufacturer were used.
The transcription reactions were treated with 3 U/µg DNA
RNase-free DNase (Pharmacia) for 10 min. The RNA
concentrations were determined by fluorimetry. The integrity and
size of the RNAs were determined by Northern analysis or staining
with ethidium bromide.
RESULTS
Deletional analysis of the 5′-end of telomerase RNA
To study the effect of RNA mutations on telomerase activity we
analyzed both the efficiency and the pattern of elongation products
produced by the enzyme in vitro. Tetrahymena telomerase can
processively elongate telomeric substrates generating a distinct 6 nt
banding pattern or periodicity (23,27). Tetrahymena telomerase
activity can be reconstituted with wild-type and mutated telomerase
RNA (12,20). To address the function of telomerase RNA
residues at the 5′-end of the telomerase RNA, including stems I
Table 1.
aNomenclature of the mutant Tetrahymena telomerase RNAs: for example
∆5′8 is a deletion of residues 1–8 from the 5′-end of the RNA; sub, substitution
t, truncation.
bTelomerase activity of Tetrahymena telomerase reconstituted with the mutant
RNAs relative to reconsitution with wild-type RNA indicated as a percentage ±
SD, with the number of times assayed and quantitated in parentheses.
cTelomerase activity of Tetrahymena telomerase reconstituted with the mutant
RNAs or wild-type assayed using the oligonucleotide d(G3T2G)3.
*For some mutants with weak activity signal intensities were between 1 and 10%:
after substraction background values were often zero. However, these mutants
clearly generated telomerase repeats, so activity was scored as <10%.
n.a., no telomerase activity.
n.d., not determinable because activity was too weak.
and II, terminal deletions of a specific number of residues were
constructed (∆5′8, ∆5′11, ∆5′15, ∆5′19, ∆5′25, ∆5′36). All
Tetrahymena telomerase RNA mutations constructed and
discussed in this paper are listed in Table 1. The numbers in the
mutation names refer to the starting position of the alteration
within the 159 nt Tetrahymena telomerase RNA. Assays were
performed in vitro using telomerase reconstituted with a fixed
amount (200 ng) of these mutated RNAs and the products were
compared with reconstituted wild-type activity (Fig. 2). Products
were quantified by comparing the signal intensity for the first
repeat in each lane using a BAS2000 PhosphorImager (Table 1
and Fig. 6). Comparison of the signal intensity for all repeats gave
similar results, however, because of the high background in
certain lanes, quantification of the signal intensity for the first
repeat was more reproducible. The signal intensity in the no RNA
lane was subtracted as background. For some mutated
telomerases with weak activity signal intensities were between 1
and 10% of the signal intensity of the elongation products of
telomerase reconstituted with the wild-type telomerase RNA.
After subtraction of the background, values were often zero. This
is due to the fact that there were differing background signals in
the different reactions. However, these mutated enzymes clearly
generated telomerase repeats, so activity was scored as <10%.
The activity reconstituted by each mutated enzyme was variable.
However, within each experiment the mutated telomerases gave
the same relative activity levels compared with each other and
with wild-type (see Figs 2–6 and data not shown).
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Figure 2. Reconstitution of telomerase activity of telomerase RNAs with
altered 5′ sequences. Elongation products of telomerase reconstituted with the
indicated mutated RNAs and assayed in the presence of [α-32P]dGTP and
dTTP and the telomeric primer d(GGGGTT)3. The RNAs used were no RNA
(lane 1), WT (lane 2), ∆5′8 (lane 3), ∆5′11 (lane 4), ∆5′15 (lane 5), ∆5′19 (lane
6), ∆5′25 (lane 7), ∆5′36 (lane 8), ∆20–36 (lane 9), ∆37–40 (lane 10), sub4–8
(lane 11), sub15–16 (lane 12) and sub26–29 (lane 13).
Terminal deletions of eight and 11 residues at the 5′-end of the
RNA decreased reconstituted activity to <20% of wild-type
reconstituted activity (Table 1). Deletion of eight residues
reproducibly resulted in less activity than deletion of 11 residues.
Deletion of 15–36 residues abolished telomerase activity in vitro,
suggesting that some or all residues between 11 and 15 may be
important for activity (Fig. 2). To specifically address the role of
the paired bases of stem I residues 4–8 were mutated from
CCCGC to AAACA (sub4–8, sub refers to substitution). In most
of the Tetrahymena telomerase RNA substitutions made and
discussed in this paper purines were replaced by pyrimidines and
pyrimidines by purines (see Materials and Methods). Deletion of
stem I (∆5′8) reduced activity to <10% and substitution of
residues 4–8 of stem I (sub4–8) reduced activity to 35% of the
level from enzyme reconstituted with wild-type RNA (Fig. 2).
Also, to address the role of the paired bases of stem I residues
103–107 were deleted (∆103–107). Consistent with substitution of
residues 4–8 in stem I, deletion of residues 103–107 decreased
activity to 34% of reconstituted wild-type activity (Fig. 3). These
changes did not abolish activity, suggesting that the long range base
paring may be important but not essential for telomerase function.
Methylation analysis implicated residues 15 and 16 in protein
binding or protein-induced RNA structure formation (17). To
determine whether such interactions might be sequence specific,
C15–A16 were changed to G15–U16 (sub15–16). This substitution
Figure 3. Reconstitution of telomerase activity of telomerase RNAs with altered
3′ sequences. Elongation products of telomerase reconstituted with no RNA
(lane 1), WT (lane 2), t146 (lane 3), t138 (lane 4), t111 (lane 5), t75 (lane 6),
∆103–107 (lane 7), ∆76–99 (lane 8), sub 133–136 (lane 9), sub121–122 (lane
10), sub89–90 (lane 11), sub 84–87 (lane 12) and sub69–72 (lane 13). Elongation
reactions were carried out in the presence of [α-32P]dGTP and dTTP and the
telomeric primer d(GGGGTT)3.
decreased telomerase activity to 38% of wild-type, suggesting that
these residues play a role in telomerase function but that the specific
nucleotides may not be essential for activity in vitro (Fig. 2).
To test the role of stem II and the adjacent conserved region the
entire stem (∆20–36) and, independently, residues 37–40 were
deleted. Deletions of stem II and the conserved region decreased
activity to 25 and 13% respectively, further supporting the role of
this region in telomerase template function (Fig. 2; 7,12). To
determine whether the loop of stem II was involved in sequence-
specific interactions, residues 26–29 were mutated from GUAA
to CAUU (sub26–29). Substitution of these residues in the loop
of stem II did not decrease telomerase activity (Fig. 2). In fact,
telomerase activity of this mutated enzyme was increased
compared with telomerase activity of telomerase reconstituted
with wild-type telomerase RNA.
Deletional analysis of the 3′-end of telomerase RNA
To address the function of telomerase RNA residues at the 3′-end
of the RNA, including stems III and IV, terminal deletions of a
specific number of residues at the 3′-end were constructed (t146,
t138, t111 and t75, t refers to truncation). To address the role of
the residues in the loop of stem IV residues 133–136 were
changed from ACUA to UGAU (sub133–136). Telomerase
assays were performed with these mutated RNAs and the level of
products were compared with reconstituted wild-type telomerase
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Figure 4. Reconstitution of telomerase cleavage activity of mutated telomerase RNAs. Telomerase was reconstituted with no RNA (lanes 1, 14), WT (lanes 2–4,
15–17), t146 (lanes 5–7), t138 (lanes 8–10) or t111 (lanes 11–13) telomerase RNA. Telomerase was reconstituted with ∆103–107 (lanes 18–20), ∆20–36 (lanes 21–23),
∆37–40 (lanes 24–26), sub84–87 (lanes 27–29) or ∆76–99 (lanes 30–32). Elongation reactions were performed using primer d(GGGGTT)3 or d(GGGTTG)3 as
indicated in the presence of [α-32P]dGTP and dTTP or [α-32P]dGTP and ddTTP. Labeled input primer indicative of cleavage activity is indicated by P. The gels were
exposed to film for 11 (lanes 1–13) or 4 days (lanes 14–32).
activity levels (Fig. 3). Deletions of as few as 13 residues at the
3′-end (t146), as large as the entire stem IV (t111) and substitution
of residues in the loop region of stem IV (sub133–136) decreased
activity to <15% of wild-type, indicating that stem IV is a
functionally important structure (Table 1 and Fig. 3). It has been
proposed that the structurally conserved kink introduced by the
GA bulge in helix IV (residues 121 and 122) may serve as a
recognition motif for protein binding (16). To test whether such
an interaction might be sequence specific the GA residues were
changed to CU (sub121–122). This substitution of the GA bulge
did not decrease telomerase activity (Fig. 3).
To examine the role of stem III the entire stem, including
residues 84–87, proposed to form a pseudoknot structure, was
deleted (∆76–99). Surprisingly, this deletion retained 63% of the
activity of wild-type reconstituted enzyme, while deletion of
stems I, III and IV (t75) almost completely abolished activity
(Fig. 3). Methylation protection analysis implicated residues 89
and 90 in protein binding or protein-induced RNA structure
formation (17). When these two positions were changed from
adenine to uracil residues (sub89–90) there was no decrease, but
a slight increase, in the level of enzyme activity compared with
wild-type. In addition, two changes were made in stem III that
were predicted to disrupt pseudoknot formation (69–72 and
84–87) and/or protein interaction (69–72) (17). The substitution
of GGUU for CCAA (sub84–87) should abolish base pairing
interaction of the pseudoknot, yet did not decrease activity from
wild-type levels. In fact, activity was increased. The other
sequences involved in pseudoknot formation have also been
proposed to interact with a protein component based on
methylation protection (17). Substitution of residues 69–72
(sub69–72) decreased activity to 53% (Fig. 3). The effects of
these changes are consistent with 63% activity levels on complete
deletion of stem III (∆76–99) (Table 1) and indicate that the
pseudoknot may not be essential for processive elongation by
telomerase in vitro.
Role of specific secondary structures in telomerase-mediated
cleavage activity
Tetrahymena telomerase possesses a specific nucleolytic activity
that can remove the terminal dG from primers containing the
telomeric repeat d(GGGTTG)n at the 3′-end (28). The G residue
at the 3′-end of these primers can align with the C residue at the
extreme 5′-end of the RNA template, where cleavage is thought
to occur. During cleavage the 3′-terminal G residue is removed
and [α-32P]dGTP is added, generating a labeled primer-sized
product. The primer specificity of the telomerase cleavage
reaction is reconstituted with synthetic telomerase RNA and
cleavage activity can be abolished by specific mutations in the
template and the upstream conserved region of the telomerase
RNA (12,20).
To determine whether regions outside the template and the
upstream conserved regions play a role in cleavage, cleavage activity
was tested using telomerase reconstituted with RNAs mutated in all
of the stem–loop structures (Fig. 4 and Table 1). All mutated
telomerases tested which had high enough levels of telomerase to
test for cleavage had cleavage activity. The primer-sized product that
results from cleavage is indicated with a P in Figure 4. The intensity
of the cleavage product varied widely between mutated telomerases
and appeared to parallel the levels of telomerase activity. The level
of reconstituted activity was similar using two different telomeric
primers, d(GGGTTG)3 and d(GGGGTT)3 (Fig. 4).
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Figure 5. Sequences in stem II and the upstream conserved region, not stems I, III or IV, define the 5′ template boundary. Telomerase was reconstituted with no RNA (lane
1), WT (lanes 2 and 3), ∆5′8 (lanes 4 and 5), ∆20–36 (lanes 6 and 7), sub26–29 (lanes 8 and 9), ∆37–40 (lanes 10 and 11), 38–40AGU (lanes 12 and 13), sub69–72 (lanes
14 and 15), ∆76–99 (lanes 16 and 17) or t146 (lanes 18 and 19). Elongation reactions were performed using primer d(GTTGGG)3 with [α-32P]dGTP and dTTP or with
[α-32P]dGTP, dTTP and dATP as indicated in the figure.
Figure 6. Bar graph representation of the telomerase activity reconstituted by the
different mutated RNAs compared with the telomerase activity reconstituted by
wild-type telomerase RNA. The error bars represent the standard deviations.
DideoxyTTP was used to determine how many residues were
added onto the primer substrates. Because the sequence at the 3′-end
of telomeric substrates specifies the first nucleotide added in
elongation reactions with telomerase (20,23) the site of termination
can be predicted. For all mutated RNAs tested, as for wild-type
RNA, ddTTP incorporation occurred four residues from the 3′-end
of the primer d(GGGTTG)3 (Fig. 4). The ability of all the mutated
telomerase RNAs tested to reconstitute telomerase cleavage activity
and incorporate ddTTP at the same position from the 3′-end of the
primers used suggests that none of the mutations affect alignment of
the cleavage substrate with the template.
Stem II and the conserved region, not stems I, III or IV,
regulate the 5′ template boundary
In wild-type Tetrahymena telomerase RNA there are two U residues
that separate the template domain from the upstream conserved
region (Fig. 1). Unlike wild-type telomerase, telomerase
reconstituted with a mutated RNA in the upstream conserved
region (38–40AGU) will copy past the template domain and
incorporate dATP into elongation products. This results in a
change in the pattern of the elongation products, compared with
the pattern of elongation products generated in the absence of
dATP (12). The incorporation of dATP into elongation products
occurs due to utilization of the U residues 5′ of the template
domain as template residues. To determine whether sequences or
structures other than the conserved region play a role in regulation
of the 5′ template boundary, telomerase enzymes reconstituted
with RNAs mutated in stems I–IV were assayed in the presence
or absence of dATP. The elongation products were compared with
the elongation products generated by telomerase reconstituted
with wild-type telomerase RNA and 38–40AGU (Fig. 5). Only
telomerase reconstituted with 38–40AGU and mutated RNAs
affecting the conserved domain, ∆20–36 and ∆37–40, had altered
patterns of elongation products in the presence of dATP (Fig. 5).
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Thus only stem II and, more specifically, the conserved sequence
associated with this stem appear to regulate the 5′ boundary of the
template. These results clearly demonstrate the role of these
residues in template function.
DISCUSSION
We identified residues in the Tetrahymena telomerase RNA that are
important for enzyme activity, either directly in catalysis or
indirectly by mediating proper RNA structure and binding to protein
components. When residues at the 5′-terminus and in stems I, II and
IV were deleted or changed, activity decreased to 15–35% of
wild-type levels. These data support the importance of these
structures in protein binding and/or RNA interactions for telomerase
activity. Interestingly, mutations affecting the potential pseudoknot
structure of the telomerase RNA, deletions of the entire stem III and
a substitution of the GA bulge in stem IV did not significantly affect
activity.
Many of the mutated RNAs descibed in this paper were in
structures predicted to have critical roles in telomerase function. Yet
many were able to reconstitute telomerase activity to wild-type
levels. Although it is possible that pieces of endogenous
Tetrahymena telomerase RNA remain following micrococcal
nuclease digestion and that these could complement the mutated
telomerase RNAs in an intermolecular manner, we think this is
unlikely. No undigested RNA was detectable after Northern analysis
of micrococcal nuclease-treated extract. In addition, no activity was
detected in the control reaction without added telomerase RNA.
Thus the reconstituted activity is likely to be due to addition of
synthetic RNA and not to complementation of synthetic RNA by
undegraded portions of the RNA (data not shown).
All of the mutated RNAs described in this paper were tested for
reconstitution of telomerase activity. It is likely that some of the
effects of the RNA mutations on telomerase activity are indirect,
via defects in binding, and it will be important to determine the
binding affinities of these RNAs to recombinant telomerase
protein components. Moreover, during transcription, the mutated
RNAs may undergo differential RNA folding and alternative base
pairing, which may affect the positioning or spacing between
critical regions of the RNA. Secondary structure analysis of these
mutated RNAs will be required to assess the different roles of
RNA folding, binding and catalysis.
Deletion of >11 residues at the 5′-end of the telomerase RNA
completely abolished activity, suggesting that important sequence or
structure interactions occur in this region. Substitution of residues 15
and 16, however, only reduced levels of reconstituted activity to
38% of wild-type, suggesting that protein contacts at these residues,
predicted by structural probing (17), are not sequence dependent and
are not the only important residues in the 5′-region.
The long range base paring interactions in stem I do not appear
to be essential for telomerase function. Of the three mutated
RNAs that affect the stem I base pairing, two, ∆103–107 and
sub4–8, decreased activity to ∼35% of wild-type levels. The fact
that the ∆5′8 mutated RNA had very low levels of activity might
be due to additional residues that are deleted in this mutated RNA
besides stem I residues. However, the ∆5′11 mutated RNA has
more activity than ∆5′8, suggesting a negative role for residues
9–11. Conservation of the long range base pairing of stem I in all
of the ciliate telomerase RNAs strongly supports the role of this
structure in telomerase function. Perhaps this region is involved in
RNA folding or RNA assembly. The protein components of
telomerase may bind the ends of the RNA and bridge this long range
interaction, so that it forms even in the absence of base pairing.
Although the conserved sequence upstream of the template
plays an essential role in telomerase function, stem II appears not
to be required. Deletion of residues in stem II (∆20–36) reduces
activity to 25% of wild-type. It is possible that this mutated RNA
forms alternative structures that compensate for deletion of stem
II. Although activity decreases only slightly more when four
residues adjacent to stem II are deleted (∆37–40), this mutated
RNA also affects template boundary determination (12). Initially
6 nt (residues 35–40) were identified that were conserved
upstream of the template. The later identification of additional
ciliate telomerase RNAs indicated that only four residues are
absolutely conserved (8,9). The placement of the template and the
upstream conserved sequence is conserved among all ciliate
telomerase RNAs identified to date, including Paramecium (4).
However, stem II is not conserved in all ciliates, suggesting that
it may not play an essential role in telomerase function. Consistent
with this, substitution of residues in the loop region of stem II
(sub26–29) did not decrease telomerase activity. Thus no
significant interactions in loop II appear to be required for
telomerase activity in vitro.
All deletions and substitutions affecting stem IV, except for a
substitution of the GA bulge at positions 121 and 122, decreased
telomerase activity to <10–15% of wild-type. This is consistent
with the high sequence conservation of stem IV. This stem has
also been suggested to mediate a conformational change
involving alternative base paring with stem II during enzyme
translocation (8). However, stem II does not appear to be essential
for telomerase activity in vitro, suggesting that any alternative base
pairing with this region may not be required for translocation.
Mutations in the conserved GA bulge bases in helix IV did not
affect telomerase activity, indicating that sequence-specific
contacts to this region are not essential. In Paramecium species and
the hypotrichs helix IV is more extended than in tetrahymenine
ciliates and the conserved GA bulge that is a distinct feature of
Tetrahymena telomerase RNAs is not apparent (4,7). Structural
probing experiments in Tetrahymena suggested that protein
interactions are likely occurring at the GA bulge (16,17). Our
finding that substitution of the GA bulge (sub121–122) does not
affect telomerase activity suggests that if interactions are
occurring at these residues, they may not be sequence dependent.
These results also indicate that any interactions which occur here
may not be required for catalysis, cleavage or translocation.
Perhaps this region interacts with regulatory proteins that are not
purified as a part of the telomerase core enzyme. However, in vivo
both a deletion of the GA bulge (∆GA) and a double mutated
telomerase RNA deleted for the GA residues and with a
substitution at position 44 in the template (44G) result in an
increased rate of cell death and shortened telomeres, indicating an
important role for these residues in vivo (29).
The pseudoknot formed by stem III is conserved in all ciliate
telomerase RNAs. Surprisingly, mutations predicted to abolish
base pairing in this region did not abolish telomerase activity. It
is possible that these mutated RNAs form alternative structures
that perform functions similar to the pseudoknot. Of all the
deletions and substitutions affecting stem III and the pseudoknot
structure only two mutations decreased activity. These were a
complete deletion of stem III, which reduced activity to 63%, and
a substitution of residues 69–72, predicted to be involved in both
pseudoknot structure and protein interactions, which reduced
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activity to 53%. Pseudoknot structures are often involved in
recognition and binding of proteins (14,15). The existence of the
pseudoknot has been verified experimentally by structural probing
and it has been suggested to serve as a conformational switch during
synthesis of telomeric DNA (7,16,17). Conservation of the
pseudoknot structure in all of the ciliate telomerase RNAs indicates
that it plays a role in telomerase function (4). Again, like the GA
bulge region in helix IV, this conserved function might not be part
of the telomerase enzyme as defined by the in vitro telomerase assay.
There may be in vivo regulators of telomerase that interact with a
conserved structure on the enzyme. Interestingly, one mutation
(sub84–87) predicted to affect pseudoknot structure formation had
increased telomerase activity. Residues 84–87 may normally be
involved in interactions which negatively regulate telomerase
activity. Similarly, one mutation in stem III (sub89–90) previously
predicted to be involved in protein binding or protein-induced RNA
structure formation (17) had increased telomerase activity,
suggesting a possible inhibitory function of these residues on
telomerase activity.
The structure and sequence of telomerase RNA has been
proposed to play a role in active site function. A detailed analysis
of the role of the template residues in telomerase function
suggests that a three-way interaction exists between the DNA
product, the telomerase RNA template region and the telomerase
proteins to promote active site function (30). The in vitro data
presented in this paper provide additional support that base-
specific interactions involving telomerase RNA residues in and
adjacent to the template are important for catalysis by telomerase.
The ability of all the mutated telomerase RNAs tested to
reconstitute telomerase cleavage activity, albeit to different
levels, and incorporate ddTTP at the same position from the
3′-end of the primers used suggests that none of the mutated
RNAs affect alignment of the cleavage substrate with the
template. Recently telomerase activity of a telomerase RNP
consisting of Tetrahymena proteins and Glaucoma telomerase
RNA was assayed (31). The telomerase RNAs from these two
species are quite different outside the 23 bases containing the
template. This hybrid enzyme had aberrant cleavage activity,
suggesting that interactions outside the template domain, perhaps
in the secondary structures, affect function at the active site (31).
Our data suggest that stem III, the pseudoknot and stem IV,
previously proposed to be involved in translocation at the active
site, are not essential in vitro for substrate alignment, cleavage,
translocation and realignment of the product DNA. Moreover,
stems I, III and IV play no role in dictating the template boundary
and, therefore, the sequence synthesized by telomerase at the
active site. Only the upstream conserved region and stem II,
presumably because the conserved region is in part contained
within stem II, are responsible for regulating addition of
nucleotides onto substrates present at the active site. A detailed
analysis of similar mutations in vivo and structural probing of
mutated RNAs within the telomerase RNP will be required to
fully understand the roles of the secondary structures of the
telomerase RNA in telomerase function.
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